Russian Fund Director Calls Anvisa Unprofessional for Banning Sputnik V in Brazil

Kirill Dmitriev also said that there may have been external pressure to not let Sputnik enter the country

Gonçalves (MG)

Kirill Dmitriev, director of the fund that financed the development of the Sputnik V vaccine, blamed the Anvisa (National Health Surveillance Agency) rejection of the Russian vaccine on possible political pressure orchestrated by the United States to "not let Sputnik enter the country."

FILE PHOTO: Chief Executive of the Russian Direct Investment Fund, Kirill Dmitriev, attends a session of the St. Petersburg International Economic Forum (SPIEF), Russia, June 7, 2019. REUTERS/Maxim Shemetov/File Photo - REUTERS

"External intervention is one of the elements of this behavior [by Anvisa]," said Dmitriev, citing a report by the United States Department of Health and Human Services that stated that the American health attaché "persuaded Brazil to reject the Russian vaccine."

Folha's reporting showed that the report on the fact was published on January 17, three days before Joe Biden's inauguration. "This is part of the policy. The documentation [Anvisa] has been asking of us is much greater and different from what it asks of other regulatory bodies and vaccine producers," said Dmitriev.

Translated by Kiratiana Freelon

Read the article in the original language